Insulin zinc
Highest phase reached
Phase 2
Drug type
Protein
- Listing at source
- Listed
- Highest phase reached
- Phase 2
- Drug type
- Protein
- Drug name
- Insulin zinc
- 150 mg suspension
- 150 mg Suspension
- 30 mg Suspension
- 400 mg Suspension
- 5 mg Suspension
- 750 mg Suspension
- compound insulin zinc suspension
- Compound insulin zinc suspension
- insulin zinc
- Insulin zinc
- Insulin zinc injection (aqueous suspension)
- insulin zinc injection aqueous suspension
- Insulin zinc purified porcine (suspension)
- insulin zinc purified porcine suspension
- insulin zinc suspension compound
- Insulin zinc suspension, compound
- Insulin zinc, purified porcine (suspension)
- JNJ-47910382 (suspension)
- suspension d insuline zinc composee
- Suspension d'insuline zinc (composee)
- Suspension de insulina cinc (compuesta)
- suspension de insulina cinc compuesta
- ChEMBL ID
- CHEMBL2108491
- First in class
- No
- Orphan designation
- No
- Prodrug
- No
- Chirality
- Single enantiomer
- Inorganic
- No
- Natural product
- No
Related records
Trials (141)
- 14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man
- 3-part Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EXS21546
- 600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fasting Conditions
- A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets
- A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients
- A Clinical Trial of TQC3721 Suspension for Inhalation
- A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
- A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease.
- A Clinical Trial on the Treatment of Idiopathic Pulmonary Fibrosis
- A Four-Way Cross-Over Study To Compare The Plasma Concentrations Of PF-02413873 After Oral Administration Of Several Doses As Suspension And As Tablets.
- A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis
- A Phase II Clinical Trial of TQC3721 Suspension for Inhalation
- A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Fasting Conditions
- A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Non-fasting Conditions
- A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD)
- A Study in Healthy Male Volunteers Investigating the Safety, Absorption and Elimination of Single Doses of GLPG4059
- A Study in Healthy Participants Investigating the Safety, Tolerability and Plasma Pharmacokinetics (PK) of Single Oral Doses of JNJ-47910382
- A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
- A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
- A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD)